This post was originally published on this site
Abbott Laboratories ABT is focused on recovering its position in the baby-formula market in the U.S. following the recall that required the intervention of the Biden administration to ensure that parents were able to feed their babies.
The recall, which was announced in February, included Similac, EleCare, and other powder-formula products manufactured at one plant in Sturgis, Mich. It came after reports of two babies dying and at least two others getting sick with a bacteria called Cronobacter sakazakii. The infants had…
